Assessment of Catheter-Associated Infection Risk with the Hickman Right Atrial Catheter
- 2 January 1984
- journal article
- research article
- Published by Cambridge University Press (CUP) in Infection Control
- Vol. 5 (5), 226-230
- https://doi.org/10.1017/s0195941700060161
Abstract
One hundred fifty Hickman right atrial catheters were inserted into 143 patients and were followed prospectively until removal. Primary indications for their use were: cancer chemotherapy (45), parenteral nutrition (35), antibiotic therapy (63), and miscellaneous (7). The overall catheter-associated infection rate was 12.0%. Since the mean duration of catheterization was 125 days, the infection/duration rate was 1.0/1,000 days of use. The risk of infection differed significantly according to the primary indication for catheterization: parenteral nutrition > antibiotic therapy > cancer chemotherapy. The increased risk of catheter-associated infection attributable to duration of catheterization was additive, and the per day risk of such infections remained constant regardless of duration. Nearly two-thirds of patients were discharged home with catheters in place, without adversely affecting infection risk.This publication has 6 references indexed in Scilit:
- Total parenteral nutrition-related infectionsAmerican Journal Of Medicine, 1982
- Risk of infection associated with the use of Broviac and Hickman cathetersAmerican Journal of Infection Control, 1982
- USE OF MODIFIED SUBCUTANEOUS RIGHT-ATRIAL CATHETER FOR VENOUS ACCESS IN LEUKÆMIC PATIENTSThe Lancet, 1980
- A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related InfectionNew England Journal of Medicine, 1977
- Infection Control in Intravenous TherapyAnnals of Internal Medicine, 1973
- Indwelling Intravenous Polyethylene CathetersPublished by American Medical Association (AMA) ,1971